Story perspectives
IVF Patients Sue Genetic Firms Over Misleading Test Claims
4/14/2026
1 of 1
Story summary
- Genomic Prediction and CooperGenomics, New Jersey genetic-testing companies, face class-action lawsuits by IVF patients alleging misrepresentations about the PGT-A test's ability to reduce miscarriage rates.
- Plaintiffs say the claims led them to discard viable embryos based on inaccurate results, causing emotional distress and financial impacts.
- The lawsuits seek damages and a jury trial.
- Genomic Prediction stated it remains committed to accuracy but cannot comment further while the case is pending.
